Stocks · Healthcare · Medical - Instruments & Supplies
Medline Inc. MDLN
$35.61 +1.92% Close, Oct 2, 2026 · NASDAQ · Market cap $30.11B
Inexpensive vs sector
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Net debt is 4.0× EBITDA, a high level of leverage.
- The diluted share count rose 9.4% in a year.
- The stock is 29% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth, 3-year CAGRBottom 49%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 26%
- Gross marginBottom 16%
- Operating marginTop 33%
- Cash conversion (OCF / net income)Top 21%
- Accruals (lower is better)Bottom 31%
- Net debt / EBITDA (lower is better)Bottom 20%
- Interest coverTop 35%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 22%
- Free-cash-flow yieldTop 13%
- EBITDA / enterprise valueTop 19%
- Sales / enterprise valueTop 15%
Strength and persistence of the price trend, including versus the S&P 500.
- 6-month returnBottom 24%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 29%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 30%
- Upside to consensus price targetBottom 29%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 42%
- Maximum drawdown, 3 yearsTop 11%
- Net debt / EBITDA (lower is better)Bottom 20%
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Gross margin | 25.0% | — | Bottom 16% | |
| Operating margin | 6.1% | — | Top 33% | |
| Net margin | 2.3% | — | — | |
| Free-cash-flow margin | 6.8% | — | — | |
| Return on invested capital | 4.0% | — | Top 26% | |
| Revenue growth, 3-year CAGR | 9.9% | — | Bottom 49% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.88×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.1%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.05×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 2.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.32%
- Net buyback yield (TTM)
- -16.79%
- Shareholder yield
- -16.48%
- Share count change, 1 year
- +9.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 27, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 2 of 3
- Average EPS surprise, last 4
- +16.0%
- Average 2-day reaction, last 8
- -7.9%
- Positive 20 days after report
- 0 of 3
Analysts
- Consensus price target
- $44.33
- Target vs current price
- +24.5%
- Analysts with a rating
- 17
- Share rating Buy or Strong Buy
- 88%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +41.9% | -12.8% | -16.7% | -16.5% | — |
| May 6, 2026 | +11.8% | -7.3% | -14.9% | -23.9% | -13.3% |
| Feb 25, 2026 | -5.6% | -3.6% | -11.2% | -15.9% | -27.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $0.50 | $0.35 | +41.9% | $7.68B |
| May 6, 2026 | $0.33 | $0.30 | +11.8% | $7.35B |
| Feb 25, 2026 | $0.22 | $0.24 | -5.6% | $7.79B |
| Nov 4, 2025 | $0.31 | — | — | $7.12B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 41.4× | — | — | Top 22% |
| P/E (forward) | 23.9× | — | — | — |
| EV / EBITDA | 15.9× | — | — | Top 19% |
| EV / Sales | 1.35× | — | — | Top 15% |
| Free-cash-flow yield | 6.73% | — | — | Top 13% |
| Earnings yield | 2.42% | — | — | Top 22% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 1
- 50-day average slope (20 days)
- -6.6%
- Distance from 50-day average
- +0.8%
- RSI (14)
- 57.0
- Relative volume
- 1.52×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 51.5%
- Current drawdown from 1-year high
- -28.8%
- Maximum drawdown, 3 years
- -36.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 24, 2026 | Sep 18, 2026 | -36.7% | 143 days | Not yet recovered |
| Dec 24, 2025 | Jan 5, 2026 | -11.9% | 6 days | 12 days (Jan 22, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $30.11B
- P/E (TTM)
- 41.4
- EPS, diluted (TTM)
- $0.86
- Revenue (TTM)
- $29.94B
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $21.45B | $23.23B | $25.51B | $28.43B |
| Gross profit | $4.56B | $5.22B | $6.29B | $7.52B |
| Operating income | $870.0M | $1.44B | $2.23B | $2.21B |
| Net income | -$25.0M | $234.0M | $1.20B | $1.16B |
| EPS (diluted) | -$0.03 | $0.30 | $1.52 | $1.43 |
| Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.18B | $6.39B | $6.64B | $6.89B | $7.12B | $7.79B | $7.35B | $7.68B |
| Net income | $292.0M | $324.0M | $322.0M | $333.0M | $322.0M | $180.0M | $129.0M | $60.0M |
| EPS (diluted) | $0.37 | $0.41 | $0.40 | $0.42 | $0.41 | $0.22 | $0.16 | $0.07 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Operating cash flow | $187.0M | $1.69B | $1.77B | $1.74B |
| Capital expenditure | -$254.0M | -$285.0M | -$364.0M | -$447.0M |
| Free cash flow | -$67.0M | $1.40B | $1.41B | $1.30B |
| Dividends paid | $0 | -$114.0M | $0 | -$518.0M |
| Net share buybacks | $0 | $0 | -$20.0M | $5.04B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $2.68B
- Total assets
- $39.35B
- Total liabilities
- $20.27B
- Total debt
- $12.64B
- Net debt
- $10.31B
- Shareholders’ equity
- $11.57B
As of Jun 27, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 41,309,561
- Days to cover
- 6.43
- Change vs previous report
- +4.6%
FINRA short interest, settlement date Sep 15, 2026.